Clinical trials
Observational Disease trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 8 |
| Recruiting | 7 |
| Active, not recruiting | 1 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 6 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 4 |
| UMC Utrecht | 3 |
| Leiden University Medical Center | 2 |
| Radboud University Medical Center | 2 |
| Andrea Romano | 1 |
| AstraZeneca | 1 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
| Change Accelerator in Respiratory Care | 1 |
| Erasmus Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease | 29 |
| Barrett Esophagus | 2 |
| Colorectal Neoplasms | 2 |
| Premature Birth | 2 |
| Recurrence | 2 |
| Alzheimer Disease | 1 |
| Anastomotic Leak | 1 |
| Autoimmune Diseases | 1 |
| Basal Cell Carcinoma | 1 |
| Bone Neoplasms | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.